Status:
COMPLETED
Implementation of Optical Diagnosis of Diminutive Colorectal Polyps: DISCARD3 Study (Incorporating AI-DETECT)
Lead Sponsor:
London North West Healthcare NHS Trust
Conditions:
Colonic Polyp
Eligibility:
All Genders
55-74 years
Phase:
NA
Brief Summary
This is a prospective feasibility study. The aim of this work is to assess the acceptability and feasibility of optical diagnosis-led care in bowel cancer screening patients undergoing colonoscopy. Th...
Eligibility Criteria
Inclusion
- Patients aged 60-74
- with +ve Faecal Occult Blood/Faecal Immunochemical test attending for screening colonoscopy within BCSP (Bowel Cancer Screening Programme)
- with an established history of adenomas attending for surveillance colonoscopy within BCSP
- Patients aged 55 - referred for screening colonoscopy following positive Bowel Scope Screening flexible sigmoidoscopy
Exclusion
- Patients with a risk profile (due to family history or other) whose follow-up will be outside standard BCSP
- Patients with inflammatory bowel disease
- Unable to consent
- Pregnancy
Key Trial Info
Start Date :
February 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2021
Estimated Enrollment :
614 Patients enrolled
Trial Details
Trial ID
NCT04710693
Start Date
February 14 2020
End Date
December 3 2021
Last Update
December 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Mark's Hospital
Harrow, United Kingdom